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Abstract.  
Background: G-quadruplex DNA structures are hypothesized to be involved 
in the regulation of gene expression and telomere homeostasis. The 
development of small molecules that modulate the stability of G-quadruplex 
structures has a potential therapeutic interest in cancer treatment and 
prevention of aging. 
Methods: Molecular absorption and circular dichroism spectra were used to 
monitor thermal denaturation, acid base titration and mole ratio 
experiments. The resulting data were analyzed by multivariate data analysis 
methods. Surface plasmon resonance was also used to probe the kinetics 
and affinity of the DNA–drug interactions. 
Results: We investigated the interaction between a G-quadruplex-forming 
sequence in the human c-kit proto-oncogene and the water soluble 
porphyrin TMPyP4. The role of cytosine and adenine residues at the loops of 
G-quadruplex was studied by substitution of these residues by thymidines. 
Conclusions: Here, we show the existence of two binding modes between 
TMPyP4 and the considered G-quadruplex. The stronger binding mode 
(formation constant around 107) involves end-stacking, while the weaker 
binding mode (formation constant around 106) is probably due to external 
loop binding. Evidence for the release of TMPyP4 upon protonation of bases 
at the loops has been observed. 
General significance: The results may be used for the design of porphyrin-
based anti-cancer molecules with a higher affinity to G-quadruplex 
structures which may have anticancer properties. 
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1. Introduction 
 
There is a large and growing interest in development and 
characterization of novel DNA binding drugs. Recently, this interest has 
focused on compounds that interact with nucleic acid sequences that adopt 
conformations other than B-DNA, in vivo [1]. Non-canonical higher order 
DNA conformations, such as G-quadruplex, might be formed transiently in 
small stretches of DNA sequences. G-quadruplex DNA is a very attractive 
target for highly selective, structure-specific therapeutic strategies, due to 
its significant structural difference from the double helix [2]. Nevertheless, 
there is little direct proof for the in vivo existence of G-quadruplex 
structures [3].  
Potentially, G-quadruplex structures can be formed in hundreds of 
thousands ofDNA sequences in the human genome [4]. G-rich sequences 
are particularly prominent in telomeres [5] and the promoter regions of 
several oncogenes such as bcl2 [6], k-ras [7], c-myc [8] and c-kit [9,10]. c-
kit is a human proto-oncogene coding for a 145–160 kDa membranebound 
glycoprotein [11]. Constitutive activation of the tyrosine kinase, the KIT 
receptor, is a central pathogenic event in most gastrointestinal stromal 
tumors.  
The human c-kit oncogenic promoter contains two stretches of 
guanine-rich tracks, designated as c-kit1 (or ckit81) and c-kit2 (or ckit21). 
The c-kit2 sequence has been shown to form a parallel G-quadruplex in 
physiological conditions [9,12]. The multimeric nature of their folding still 
remains unclear. Recently, NMR-based studies showed that this sequence 
may adopt two distinct all-parallel-stranded conformations in a slow 
exchange, one of which forms a monomeric G-quadruplex (form-I) in 20 
mM K+-containing solution and the other a novel dimeric G-quadruplex 
(form-II) in 100 mM K+-containing solution [13]. In both cases, the strand 
concentration of the samples was maintained between 0.2 and 4.0 mM. The 
c-kit2 promoter monomeric form-I G-quadruplex adopted an all-parallel 
topology with two single-nucleotide reversal loops (C5 and A17, 
respectively) and one long reversal loop (C9G10C11G12A13). The 3D 
structure showed these loops lying practically externally to the G-
quadruplex core, where they are prone to interactwith ligands such as 
porphyrins or protons. This intramolecular G-quadruplex structure had four 
3′-end guanine bases. The guanine located at the 5′-end of this G-tract 
could assume either a loop or tetrad position leading to an intrinsic loop 
isomerism. Two energetically favorable loop isomers that are in dynamic 
equilibrium were proposed (Scheme 1). These are designated as a blunt-
end conformer (1:5:2), in which only one loop is consisted of a single 
nucleotide, and a dangling-end conformer (1:5:1), in which two loops 
consisted of single nucleotides. In contrast, the c-kit2 promoter dimeric 
form-II G-quadruplex adopts an unprecedented all-parallel-stranded 
topology, in which individual c-kit2 promoter strands span a pair of three-G-
tetrad-layer-containing, all-parallel-stranded G-quadruplexes aligned in a 3′ 
to 5′-end orientation, with a stacking continuity between G-quadruplexes 
mediated by a sandwiched AA non-canonical base pair. 
Among small molecules, porphyrins have been shown to bind to and 
stabilize different types of G-quadruplexes and, in some cases, to facilitate 
G-quadruplex formation [7,14–19]. The cationic porphyrin mesotetrakis-(N-
methyl-4-pyridyl)-porphyrin (TMPyP4) is the most extensively studied drug 
[1,5,20]. Evaluation of the binding affinity and specificity of drugs for G-
quadruplex DNA rely mainly on low resolution structural techniques such as 
UV–visible absorption spectroscopy and circular dichroism spectroscopy 
[21]. However, the measured signal contains a contribution from all the 
species present, which have different specificities and relative affinities to 
their ligands. It is presently unclear how conformational isomerism of G-
quadruplex influences ligand binding. In this study, we employed a powerful 
method of multivariate curve resolution to extract previously unknown 
information about the effect of protonation in the loops of G-quadruplex 
structure on its affinity to porphyrin ligand TMPyP4. To our knowledge, the 
interaction between the intramolecular G-quadruplex formed by the c-kit2 
sequence and the porphyrin ligand TMPyP4 has not been established. Apart 
from the paper by Gunaratnam et al. [19], no data have been reported on 
the number of binding sites, the strength and the influence of pH on 
porphyrin binding. In the present study we also used biophysical tools to 
assess the interaction between TMPyP4 and the G-quadruplex-forming 
sequence in c-kit. 
 
 
 
 
 
Scheme 1. Schematic representation of two loop isomers of c-kit G-quadruplex 
DNA. Dangling-end conformer (left) has one flanking nucleotide and one nucleotide 
in the third loop and blunt-end conformer (right) has two nucleotides in the third 
loop and no flanking nucleotide [28]. The white square represents a G-tetrad. 
 
2. Materials and methods 
 
2.1. Reagents 
TMPyP4 was an analytical grade reagent purchased from Sigma 
Aldrich and was used without further purification. Stock solutions were 
prepared in MilliQ® water, stored at −20 °C and diluted to working 
concentrations in MilliQ water immediately before use. The composition of 
quadruplex stabilizing buffer (QSB) was 7 mM KH2PO4, 10 mM Na2HPO4, 147 
mM KCl pH 7.2. Oligonucleotide 5′-d [CG3CG3CGCGAG3AG4]-3′, 
designated as ckit2, was a G-quadruplex forming element in the promoter 
region of the human c-kit protooncogene. Oligonucleotide 5′-
d[TG3TG3TGTGTG3TG4]-3′, designated as ckit2T, was a mutated sequence 
in which adenine and cytosine bases of the wild type ckit2 were 
systematically replaced with thymine (Table 1). Two additional sequences 
ckit2T18 and ckit2T21 were designed to eliminate the dangling-end to 
blunt-end equilibrium. These oligonucleotides, and the 3′ biotin-labeled 
ckit2 and ckit2T, were prepared as described elsewhere [22]. 
Oligonucleotide concentration was determined by UV absorbance 
measurements at 260 nm using calculated extinction coefficients 
approximated by the nearest-neighbor method. 
 
2.2. Instrumentation 
Absorbance and CD spectra were measured using an Agilent HP8453 
photo diode array spectrophotometer and a Jasco J-810 spectropolarimeter, 
respectively. Both were equipped with a stirrer and Peltier units mounted in 
the spindle of the thermoelectric cuvette holders. Biosensor SPR 
experiments were performed with a four serial channel T100 (BIAcore, Inc.) 
optical biosensor system and streptavidin-coated sensor chips (Sensor chip 
SA; BIAcore, Inc.). 
 
2.3. Procedures 
Melting curves were collected on the J-810 instrument. 
Oligonucleotides were annealed and degassed by raising the temperature to 
90 °C for 10 min and then cooling to 25 °C prior to the melting experiment. 
Samples were then heated at a linear temperature ramp of 0.3 °C/min with 
a data collection beginning at 25 °C and ending at 90 °C. The spectral 
bandwidth was 1 nm and the hold time was 1 min. A blank dataset taken 
from the buffer solution alone was also recorded and used for blank 
subtraction. Melting temperature (Tm) values are the average values of at 
least a pair of Tm values recorded during repeated melting experiments.  
Acid–base titrations were performed for several mixtures of ckit2 and 
TMPyP4, and ckit2T and TMPyP4. The pH values were determined with an 
Orion SA 720 pH/ISE meter and a microcombination pH electrode (Thermo). 
The pH of the solutions containing each of the above mixtures was adjusted 
by adding small volumes of HCl or NaOH stock solutions. Following this, the 
absorbance spectra were recorded using an Agilent spectrophotometer pH 
stepwise.  
To determine the equilibrium constants for the binding interactions, 
titration experiments were conducted using UV–vis, CD and SPR. In the UV–
vis procedure, first the spectrum of pure TMPyP4 (or pure DNA) in QSB was 
recorded. This sample was then titrated by increasing the volumes of the 
DNA solution (or TMPyP4) in such a way that the resulting CTMPyP4:CDNA (or 
CDNA:CTMPyP4) ratios were gradually lowered. Each titration was done at time 
intervals of 10 min with a magnetic stirrer on. Spectroscopic signals from 
the resulting mixture were recorded stepwise. Finally, the spectrum of a 
pure DNA (or TMPyP4) solution was recorded. In the CD procedure, first the 
CD spectrum of the pure DNA solution (ckit2 or ckit2T) in QSB was 
recorded. TMPyP4 was added to progressively increase the concentration of 
the ligand. The CD spectrum of the mixture was recorded stepwise. Finally, 
the CD spectrum of the pure porphyrin drug was recorded. For the SPR 
measurements, the streptavidin sensor chip surface was prepared for DNA 
immobilization with a regeneration buffer (1 M NaCl in 50 mM NaOH). It 
was then extensively washed with a running buffer. The running buffer was 
sterile filtered and degassed HBS-EP buffer (0.01 M HEPES (pH 7.4), 3 mM 
EDTA, and 0.005% surfactant Tween 20 with 0.1 M NaCl) fortified with 150 
mM of KCl at pH 7.2. The 21mer 3′-biotinylated ckit2 and ckit2T in running 
buffer were immobilized on flow cells 2 and 4 respectively. The 3′ 
biotinylated ckit2 with a poly(A) linker was immobilized on flow cell 3 to 
check the potential influence of the linker on binding. Flow cell 1 was 
coupled with biocytin and left as a blank control to characterize any non-
specific binding. After immobilization, the structures were equilibrated by 
passing a running buffer over the surface for 1 h at 60 µl/min flow rate to 
attain base line stability. Plastic vials were randomly positioned in the rack 
to minimize systematic errors. Following this, dissociation from the surface 
was monitored for 60 s in a running buffer. The concentration ranges for 
TMPyP4 were 0, 0.01–0.08, 0.1 and 0.2 µM. Two samples (0, 0.06 µM) 
were replicated. Suitable blank control injections (zero concentrations) with 
a running buffer were performed. 
 
Table 1 Sequences of c-kit loop variants used in this study. 
 
Name 5’  L1  L2  L3  3’ 
ckit2 C GGG C GGG CGCGA GGG A GGG G 
ckit2T T GGG T GGG TGTGT GGG T GGG G 
ckit2T18 C GGG C GGG CGCGA GGG AT GGG  
ckit2T21 C GGG C GGG CGCGA GGG A GGG T 
 
 
 
Fig. 1. CD spectra of ckit2 and mutants. CD spectrum of ckit2 (continuous black 
line), ckit2T (dashed red line), ckit2T18 (dotted blue line) and ckit2T21 (dash–dot 
green line). T=25 °C, pH=7.1. (For interpretation of the references to color in this 
figure, the reader is referred to the web version of this article.) 
 
 
2.4. Data analysis 
In this study, the hard-modeling analyses of acid–base and mole-
ratio experiments were carried out using the EQUISPEC program [23]. The 
soft-modeling analysis was undertaken with the graphic user interface of 
MCR-ALS [24], which is freely available at www.mcrals.info. As the details 
of the multivariate analysis have been explained extensively elsewhere [25–
27], only a short description is given here as Supplementary material. 
 
3. Results 
 
Table 1 shows the DNA sequences studied here. In previous works, 
the solution equilibria of the ckit2 sequence were studied [9,26]. 
Spectroscopically-monitored melting experiments provided a value of Tm 
(74±1 °C), which was shown to be independent of concentrations over the 
range 0.5 to 5 µM. This suggests that an intramolecular folding has 
occurred. Acid–base titration experiments showed that the G-quadruplex 
structure was well maintained over the pH range from 3 to 7, 
approximately. In this pH range, only one macroscopic pH-induced 
transition at around pH 4.4 was observed. This was attributed to the 
protonation of adenine and cytosine bases located at the loops. 
Simultaneously, we studied the solution equilibria of the ckit2T sequence, in 
which all bases at the loops have been mutated to thymine. The Tm value 
determined at pH 7 was slightly higher than that for ckit2 (78±1 °C). Acid–
base titrations displayed no transition over the pH range of 3 to 7 because 
of the lack of protonable nucleobases. 
 
3.1. Conformational equilibrium for ckit2 is shifted to the dangling-end 
conformer 
Fig. 1 shows the CD spectra for ckit2 and for the mutated sequences 
ckit2T18 and ckit2T21. The mutation of a guanine by a thymine in the last 
two sequences reduces strongly the potential conformational heterogeneity 
in ckit2 by constraining loop isomerism. The CD spectrum of G-quadruplex 
is known to demonstrate the nature of the folding (parallel, antiparallel or 
mixed), depending on the shape and intensity of the bands at 260 and 295 
nm. The CD spectrum of the ckitG2T18 sequence, the third loop of which 
contains two bases, shows a relatively high intensity of the band at 295 nm. 
This indicates a significant contribution from an antiparallel conformation. In 
contrast, the spectrum of ckit2T21, the third loop of which contains only a 
base, shows a predominant contribution of the parallel conformation 
(intense band at 260 nm and small shoulder at 295 nm). The CD spectrum 
for the wild type ckit2 sequence is very similar to that displayed by 
ckit2T21, which points out to a similar spatial arrangement. This fact, as 
well as the previously shown superimposable cross peaks in the NOE 
spectra [28], indicates that the dangling-end to blunt-end equilibrium is 
shifted to the former one for the ckit2 sequence. Finally, the ckit2T 
sequence shows clearly a parallel structure, without any significant 
contribution at 295 nm. 
 
3.2. TMPyP4 interacts with ckit2 and ckit2T at pH 7 
The interaction of the ligand TMPyP4 with the G-quadruplex formed 
by ckit2 and ckit2T was studied by using molecular absorption and CD 
spectroscopies at pH 7 and 25 °C. Fig. 2a shows changes observed in the 
absorption band of the ligand upon the addition of the c-kit2 sequence. 
After the addition of 3 equivalents of DNA, a bathochromic shift of up to 18 
nm and 70% hypochromicity at 422 nm were observed. These features 
imply a relatively strong binding. Fig. 2b shows the CD spectra of ckit2 and 
of a mixture of TMPyP4 and ckit2. The shape of the CD spectrum in the UV 
region is related to a parallel G-quadruplex topology [9,29,30]. Upon an 
interaction with the ligand, the shape of the CD spectrum remains 
unaltered, and only small variations in CD intensity were observed at 240, 
260 and 295 nm. A weak negative induced CD signal was observed around 
440 nm, indicating slight changes in the chiral environment of the flat drug, 
probably due to stacking [31]. Since absorbance occurs at the induced CD 
wavelength, the signal to noise ratio is compromised.  
A different spectral behavior was observed for the mutated sequence 
ckit2T. Molecular absorption spectra (Fig. 2c) clearly showed the interaction 
between the DNA and the ligand. A shift of up to 16 nm and 66% 
hypochromicity at 422 nm were observed after the addition of 3 equivalents 
of DNA. The results suggest that the binding of TMPyP4 to ckit2T is slightly 
weaker than ckit2. The most surprising fact is the absence of any induced 
CD band in the visible region of the spectrum (Fig. 2d), which suggests a 
different interaction mechanism. 
 
3.3. Melting experiments 
Thermal melting studies of mixtures of TMPyP4 with ckit2 and ckit2T 
were studied by CD and molecular absorption spectroscopy. Raw CD spectra 
are included as a Supplementary material (Fig. S1). The induced band at 
440 nm disappeared when the temperature was raised, which suggests that 
the ligand is released from the G-quadruplex structure. Concomitantly, the 
ellipticity at 260 nm was dramatically reduced whereas the overall spectral 
shape remained unaltered. These observations were probably related with 
the fact that at 90 °C there was still a small portion of folded DNA 
(Tm=74±1 °C). Fig. 3 shows the variation in CD intensity at 263 nm upon 
heating for the isolated strands and for the corresponding mixtures with 
TMPyP4. For both sequences, an interaction with TMPyP4 produced a shift in 
the measured CD signal at 263 nm, which indicates preferential binding with 
the folded structure over the unfolded strand. For ckit2 the shift was around 
10 °C, whereas a larger shift for ckit2T can only be guessed. The shift 
reported in the case of ckit2 was clearly lower than that determined 
previously using FRET [19] (21 °C). The difference could be due to the 
slightly different experimental conditions used and the fact that the studied 
sequence was shorter (21 nucleotides against 26), and lacked terminal 
fluorescent labels. 
 
  
 
Fig. 2. Interaction of TMPyP4 with ckit2 and ckit2T. (a) Visible absorption spectra 
of a 1.6 µM solution of TMPyP4 (solid black line) and of a mixture of TMPyP4 (1.6 
µM) and ckit2 (4.8 µM). (b) CD spectra of ckit2 (3 µM, solid black line) and of a 
mixture of ckit2 and TMPyP4 (3 and 9 µM, respectively). (c) Visible absorption 
spectra of a 1.7 µM solution of TMPyP4 (solid black line) and of a mixture of 
TMPyP4 (1.6 µM) and ckit2T (5.0 µM). (d) CD spectra of ckit2T (2.6 µM, solid black 
line) and of a mixture of ckit2 and TMPyP4 (2.5 and 7.4 µM, respectively). T=25 °C, 
pH=7.1. (For interpretation of the references to color in this figure, the reader is 
referred to the web version of this article.) 
 
 
 
 
 
Fig. 3. CD-monitored melting experiments. (a) Variation of CD ellipticity at 263 nm 
upon heating for ckit2 (2.4 µM, thin line) and for a mixture of ckit2 and TMPyP4 
(2.4 µM and 7.4 µM, thick line). (b) Variation of CD ellipticity at 263 nm for ckit2T 
(2.5 µM, thin line), and for a mixture of ckit2T and TMPyP4 (2.5 and 7.4 µM, thick 
line). pH=7.1. 
 
3.4. Spectroscopically-determined binding constants 
Spectroscopic mole-ratio direct and inverse titrations were 
performed. The recorded spectra were initially arranged in matrix D and 
later analyzed with the Equispec hard-modeling method. This procedure 
determines the binding constant and the pure spectra of DNA:ligand species 
formed during titration according to a defined stoichiometry. As an 
example, Fig. 4 shows the results obtained after Equispec analysis of a set 
of molecular absorption spectra measured along the titration of a ckit2 
sample with TMPyP4. The recorded spectra have been included as a 
Supplementary material (Fig. S2). In this case, the best fit was a model 
with a strong binding site and two equivalent weaker binding sites. The 
simplest 1:1 (DNA:ligand) model did not provide a good fit at higher ligand 
concentrations. The calculated binding constants are summarized in Table 
2, and the calculated distribution diagram for this mole-ratio experiment is 
shown in Fig. 4a. In addition, the calculated pure spectra for each one of 
the species involved in the equilibria are shown in Fig. 4b. The interaction of 
TMPyP4 with ckit2 produced up to 68% hypochromicity, along with a red 
shift of up to 19 nm in the calculated spectrum for the 1:3 species. Mole-
ratio titrations monitored with circular dichroism spectroscopy were also 
performed (Fig. S3). Upon addition of the ligand, the intensity of the CD 
band at 245 and 263 nm decreased significantly, and a small induced CD 
band appeared around 440 nm. In order to confirm that this signal was not 
an artifact due to the high absorption of TMPyP4 in this region, additional 
titrations were performed at lower TMPyP4 concentrations. The appearance 
of this signal even at low concentrations of TMPyP4 was confirmed. The 
spectra shown in Fig. S3 were deconvoluted using the set of stability 
constants calculated from the mole-ratio experiments monitored with 
molecular absorption spectroscopy. The calculated pure CD spectrum for 
each species is shown in Fig. 4c. Overall, the CD signature in the UV region 
denotes that the parallel structure was maintained for the two DNA:ligand 
interaction species. However, the 1:3 species showed a lower molecular 
ellipticity and the induced CD signal appeared in the visible region.  
Moreover, the interaction of TMPyP4 with the mutated sequence 
ckit2T has been studied (Fig. S4 and S5). The interaction of TMPyP4 with 
ckit2T gave a slightly different result (Fig. 5 and Table 2). The model that 
best fits the data included a strong binding site and one weak binding site. 
The values of the equilibriumconstants for theweaker binding sites were 
similar to those determined for ckit2. In contrast, the equilibriumconstant 
for the stronger binding sitewas slightly lower than that in the case of ckit2, 
a fact which is correlated with the lower shift and hypochromicity values 
observed experimentally. 
 
 
 
 
 
Fig. 4. Spectroscopically-determined binding constants for ckit2 sequence. (a) 
Distribution diagram calculated with Equispec. (b) Calculated pure molecular 
absorption spectra. (c) Calculated pure CD spectra. Solid black line: G-quadruplex 
ckit2; dotted blue line: 1:1 (DNA:ligand) complex; dash–dotted red line: 1:3 
complex; dashed green line: TMPyP4. T=25 °C, pH=7.1. (For interpretation of the 
references to color in this figure, the reader is referred to the web version of this 
article.) 
 
 
3.5. Surface plasmon resonance-determined binding constants 
SPR was used to obtain complementary information on the binding of 
ligands to the aforementioned G-quadruplex structures considered in this 
study. Fig. 6 shows the results obtained both in the steady-state and kinetic 
analysis. To a first approximation, the binding curves were fitted using the 
1:1 (DNA:ligand) model. The equilibrium formation constants calculated for 
the interaction of TMPyP4 with ckit2 and ckit2T were 107.1 and 106.9, 
respectively (Supplementary material). These fits were improved when the 
two-site model was considered. Hence, the formation constants for ckit2 
were 108.0 and 106.7, whereas the calculated formation constants for ckit2T 
were equal (10 .0 and 106.6).  
The corresponding rate and equilibrium constants were also provided 
by fitting the sensorgrams to complex kinetic models. As for the steady-
state studies, the best results were obtained when the two-site model was 
used. This suggests that TMPyP4 had a stronger binding site in the order of 
108 on the G-quadruplex along with a weaker secondary binding interaction 
in the order of 106 (Table 3). Qualitatively, this result agrees with those 
previously obtained from spectroscopic measurements. 
 
Table 2 Binding parameters obtained from UV–visible titration experiments. 
 
Sequence pH % 
Hypochromicity 
at 422 nm 
shift of the 
Soret band 
Log Ka1(M-
1) 
n1 Log Ka2(M-
1) 
n2 
ckit2 7.1 70 18 7.4(0.2) 1 6.7(0.3) 2 
 3.0 69 18 7.6(0.1) 1 5.8(0.2) 1 
ckit2T 7.1 66 16 7.1(0.1) 1 5.7(0.1) 1 
 3.0 65 16 7.2(0.3) 1 6.0(0.4) 1 
 
 
3.6. pH-induced binding changes 
Mole-ratio experiments provide quite a reliable picture of the situation 
at a fixed pH value. To gain information about the influence of pH (and the 
consequent protonation of functional groups in the nitrogenated bases), 
acid–base titrations of the mixtures of ckit2 (or ckit2T) with TMPyP4 in the 
pH range of 7 to 1 were investigated spectroscopically. Firstly, the acid–
base behavior of TMPyP4 was studied in the mentioned pH range (see 
Supplementary material, Fig. S7). A shift of the Soret band from 422 nm 
(pH 7) to 448 nm (at a pH of around 1.5) was observed. The experimental 
spectra were arranged in data matrix D and analyzed by means of Equispec. 
A simple acid– base equilibrium model was proposed and the calculated pKa 
for the proposed equilibrium was 1.7±0.1 at 25 °C and 150 mM ionic 
strength. However, the accurate determination of this pKa is difficult 
because of the concomitant increase in ionic strength when the pH is 
lowered to values below 2, approximately. The calculated pKa value agrees 
with other values reported previously [32]. The result was explained in 
terms of the protonation of nitrogen atoms located in the porphyrin moiety.  
The UV–visible molecular absorption spectra recorded during the 
titration of a mixture of ckit2 and TMPyP4 (1:4) at 25 °C are shown in the 
Supplementary material (Fig. S8). According to the calculated equilibrium 
constants at pH 7, at this ratio of concentrations almost all binding sites in 
ckitG2 are occupied by ligand molecules. The Soret band was initially 
located around 427 nm at pH 7. Based on the results obtained from the 
mole-ratio studies at pH 7, this indicates binding. The observed difference 
between 441 nm (the calculated wavelength for the fully complexed ligand) 
and 427 nm (the experimental value) was due to the presence of an excess 
of free, unbounded drug. At pH under 6, the Soret band shifts to shorter 
wavelengths, which is indicative of the release of free TMPyP4 from the 
complex. At pH 3, the band is centered at 422 nm, which is the position of 
free deprotonated TMPyP4. At even lower pH values, the band moves to 
longer wavelengths, according to the observed trend for protonated 
TMPyP4. Experimental spectra were arranged in data matrix D and analyzed 
by means of MCR-ALS, a soft-modeling approach. The number and 
complexity of the chemical equilibria in the mixture made it difficult to apply 
a hard-modeling approach like Equispec. The resolved distribution diagram 
and pure spectra, which are shown in Fig. 7a and b, reflect the 
experimentally observed facts. 
Hence, the data were well explained when only three species were 
considered. The first species is related to the initial mixture of the 1:3 c-
kit2: TMPyP4 complex and unbounded TMPyP4 at pH 7. The second species 
is the major one at pH 3. The midpoint of this transition is located around 
pH 4.4, which is also the location of the only transition induced by the pH 
observed for free c-kit2 [26]. This has been related to the protonation of 
bases at the loops. Accordingly, the major species at pH 3 have been 
related to a mixture of c-kit2 (where bases at the loops are protonated) and 
free deprotonated TMPyP4. The additional positive charge at the loops 
removes the ligand from the G-quadruplex. At even lower pH values, the 
protonation of TMPyP4 is observed (pH transition midpoint around 2) and 
the Soret band moves to 443 nm.  
The role of the protonation of the cytosine bases at the loops was 
checked by carrying out a similar acid–base titration of a mixture of TMPyP4 
and ckit2T. This sequence lacks cytosine and adenine bases at the loops, 
whereas the G-quadruplex structure is still well maintained [26]. The acid–
base titration of the ckit2T: TMPyP4 (1:2.5) mixture did not show any 
spectral change over the pH range 2–7, and a shift from 428 to 443 nm was 
only observed at pH below 2, concomitant with the protonation of TMPyP4 
(see the Supporting material, Fig. S9). The MCR-ALS analysis indicated that 
the experimental data could be explained satisfactorily with only one acid– 
base transition (Fig. 7c–d). In this case, the transition was located around 
1.8 and was explained in terms of the protonation of TMPyP4. 
 
 
 
 
  
Fig. 5. Spectroscopically-determined binding constants for ckit2T sequence. (a) 
Distribution diagram calculated with Equispec. (b) Calculated pure molecular 
absorption spectra. (c) Calculated pure CD spectra. Solid black line: G-quadruplex 
ckit2T; dotted blue line: 1:1 (DNA:ligand) complex; dash–dotted red line: 1:2 
complex; dashed green line: TMPyP4. T=25 °C, pH=7.1. (For interpretation of the 
references to color in this figure, the reader is referred to the web version of this 
article.) 
 
 
 
 
Fig. 6. SPR results for the interaction of TMPyP4 with ckit2 and ckit2T. (a) and (c) 
show the steady state affinity (1:2 model) plot for the interaction of TMPyP4 with 
ckit2 and ckit2T, respectively. (b) and (d) show the SPR sensorgrams (black) with 
fitting (grey) for the interaction of TMPyP4 with ckit2 and ckit2T, respectively, when 
the heterogeneous ligand model was considered. The concentration of TMPyP4 
increased from 110−8 M to 310−7 (upper curve). The experiments were carried out 
in 10 mM HEPES buffer, 3 mM EDTA, 0.005% surfactant Tween 20, 150 mM KCl, pH 
7.2, at 25 °C. 
 
 
Table 3 Thermodynamic and kinetic parameters obtained from SPR. Results 
obtained from simultaneous analyses of two independent experiments. pH 7.1, 25 
°C. 
Sequence Affinity (Two sites) Kinetics (Heterogeneous ligand) 
 log Ka1 log Ka2 ka1 
(1/Ms) 
kd1 (1/s) log Ka1 
(M-1) 
ka2 
(1/Ms) 
kd2 (1/s) log Ka2 
(M-1) 
ckit2 8.0 6.7 5.54·10-6 0.0401 8.1 1.15·106 0.3335 5.5 
ckit2T 8.0 6.6 5.59·106 0.0272 8.3 1.17·106 0.3223 6.5 
 
 
3.7. Mole-ratio studies at pH 3.5 
Mole-ratio experiments were performed at pH 3.5, where most of the 
cytosine and adenine bases present at the loops of ckit2 were already 
protonated (Fig. S10). The experiments carried out for ckit2 showed the 
formation of two complexes with stoichiometries 1:1 and 1:2 (DNA:ligand), 
and with equilibrium constants equal to 10 6.8 and 10 6.3i.e., two different 
binding sites were considered. The CD spectra measured for a mixture of 
ckit2 and drug showed the negative induced CD band around 440 nm 
observed at pH 7 (Fig. S11) disappeared.  
In the case of ckit2T (Fig. S12), the results of mole-ratio experiments 
at pH 3.5 were very similar to those obtained previously at pH 7.1. The 
analysis of the data (Supplementary material) was successful when two 
complexes with stoichiometries of 1:1 and 1:2 (DNA:ligand) were used, 
with equilibrium constants equal to 107.2 and 106.0 i.e., two different binding 
sites were considered. The spectral shift, hypochromicity and binding 
constant values were similar to those determined at pH 7.1, which indicates 
that the binding mode was similar. 
 
 
Fig. 7. Spectroscopically monitored acid–base titration of mixtures of TMPyP4 and 
ckit2, and TMPyP4 and ckit2T. Calculated distribution diagram (a) and pure 
molecular absorption spectra (b) for the mixture of TMPyP4 and ckit2. Continuous 
black line: mixture of the 1:3 complex and free unbounded TMPyP4. Dashed line: 
mixture of ckit2 (with protonated cytosines) and deprotonated TMPyP4. Dotted gray 
line: mixture of ckit2 (with protonated cytosines) and protonated TMPyP4. 
Calculated distribution diagram (c) and pure molecular absorption spectra (d) for 
the mixture of TMPyP4 and ckit2T. Continuous black line: mixture of the 1:2 
complex and free unbounded TMPyP4. Dotted gray line: mixture of ckit2T and 
protonated TMPyP4. 
 
 
4. Discussion 
Spectroscopic techniques along with multivariate data analysis may 
become useful tools to generate plausible binding mechanisms. The present 
study examines one such case, by proposing a drug binding mechanism for 
a complex system involving G-quadruplex DNA. Multivariate data analysis 
was used to detect small absorbance and ellipticity changes manifested in 
response to subtle structural rearrangements during mole-ratio and acid–
base titration experiments. The multivariate curve resolution technique 
added two important values to the spectroscopic data. First, it helped to 
extract new structural variants that would otherwise be indistinguishable in 
these spectroscopic techniques. Second, it helped to estimate 
thermodynamic parameters from the distribution diagrams. The 
combination of these tools was used to determine the affinity, specificity 
and binding mechanisms of the DNA drug interactions.  
Based on NMR data, Hsu et al. proposed that the ckit2 sequence 
exists as an ensemble of at least two structures that share the same 
parallel-stranded propeller-type conformations, and which undergo slow 
interconversion on the NMR timescale (Scheme 1) [28]. In spite of the 
changes at the loops, the overall parallel structure of ckit2 seems to be 
conserved in the mutated sequence ckit2T, as the CD spectrum and Tm 
value are similar. The small difference observed (74 versus 78 °C) may be 
due to the substitution of adenine bases at the loops, whose destabilizing 
effect in G-quadruplex structures has been suggested previously [33]. 
At pH 7.1, our results suggest the existence of three binding sites for 
ckit2 in the presence of a moderate excess of TMPyP4. One of these binding 
sites shows a stronger affinity (around 107) than the other two (around 
106). This is in accordance with the previous models proposed by other 
authors. A 1:3 (DNA:ligand) stoichiometry was proposed for the interaction 
of TMPyP4 with the parallel intramolecular G-quadruplex formed by a 
sequence corresponding to the NHE III1 element of the c-myc oncogene 
[34], the structure of which is similar to that proposed for c-kit2 [35]. 
These authors proposed that the interaction of TMPyP4 with parallel 
quadruplexes takes place through three binding sites, one with a stronger 
binding (107) involving end-stacking over the end G-tetrad, and two binding 
sites with a weaker external binding (106). Other authors have proposed 
similar stoichiometries and binding modes. Wei et al. [36] proposed that 
three TMPyP4 molecules bind to the parallel four-stranded (TG4T)4 DNA with 
two independent binding sites of similar affinity to those determined in our 
study. Interestingly, the binding stoichiometry seems to be different for a 
similar porphyrin (TPrPyP4) in a Na+-containing medium [37].  
Besides the existence of two binding sites with a different affinity, the 
number of TMPyP4 molecules bound to parallel G-quadruplex DNA depends 
on the sequence considered. Hence, Han et al. suggested that TMPyP4 binds 
to parallel G-quadruplex through external stacking at the ends with two 
molecules of ligand bound per quadruplex at saturation [15]. Parkinson et 
al. [38] reported the crystal structure of a DNA:TMPyP4 complex involving 
the bimolecular parallel G-quadruplex formed by a sequence corresponding 
to the human telomere. The particular sequence studied in this paper has 
several adenine and thymine bases at the loops. Consequently, TMPyP4 
molecules did not stack directly onto the G-tetrad core but onto AT base 
pairs and TT and TTA loops. The authors reported two main binding sites in 
the experimental conditions used in their study. Despite the fact that the 
conformation is similar to that shown by ckit2 (parallel), the role of bases in 
the loops seems to be crucial. 
It should be stressed that the methodology used in this study 
(spectroscopy hyphenated to multivariate analysis) could not deconvolute 
all three DNA:ligand complexes. The pure spectra and the formation 
constant for the 1:2 (ckit2:TMPyP4) complex could not be resolved. This 
fact is related to the equal spectral characteristics of 1:2 and 1:3 
complexes, which hinder the mathematical resolution of the chemical 
system. It may be hypothesized that the similar spectral features of both 
complexes are due to the binding of TMPyP4 to very similar sites on the G-
quadruplex. Another previously proposed possibility would be the existence 
of two sequential binding events, a first in which one molecule of TMPyP4 
interacts with the quadruplex structures and a second in which more 
molecules bind to the structure [5].  
At pH 7.1, the interaction of TMPyP4 with ckit2 led to the appearance 
of a weak negative induced CD band. A similar finding was reported for the 
interaction of TMPyP4 with a parallel G-quadruplex within the promoter 
region of the k-ras gene [7] or with a hybrid antiparallel/ parallel G-
quadruplex within the promoter region of the bcl-2 gene [27]. A comparison 
of the intensity of the induced CD signal with those previously reported for a 
hairpin formed by a cytosine-rich sequence of the bcl-2 gene [25] or for 
duplex DNA [39] indicates that intercalation produces stronger induced CD 
signals than end-stacking. Multivariate analysis of spectroscopic data 
revealed that this induced CD band is characteristic of the 1:3 complex. In 
contrast, the 1:1 complex did not show this band. Similarly, the shift of the 
absorption band in the Soret region for the 1:3 complex is small compared 
to the 1:1 complex, a fact that is related to a weaker binding. At pH 7, the 
interaction of TMPyP4 with the mutated sequence ckit2T is slightly different 
to that observed for ckit2 as only one weak binding site was detected and 
no induced CD band appeared. 
 
 
 
 
Scheme 2. Proposed mechanism for the interaction of TMPyP4 with ckit2 (left) and 
ckit2T (right). 
 
Acid–base titrations showed that just one of the binding sites in ckit2 
is dramaticallymodified by the protonation of bases such as cytosine and 
adenine,whose pKa values are around 4. As expected, decreasing the pH 
value from 7 to 3 did not affect the binding mechanism of ckit2T, as it lacks 
cytosine and adenine bases. This site in ckit2 would be responsible for the 
negative induced CD band.  
Scheme 2 shows the proposed mechanism for the interaction of 
TMPyP4 with ckit2 and ckit2T under the experimental conditions. The 
existence of three binding sites in ckit2 is proposed. The strongest site 
corresponds to the end-stacking binding onto a G-tetrad. The location on 
the upper or bottom G-tetrad is still a matter of discussion. Whereas the 3′-
end seems the most appropriate place for an intramolecular parallel 
structure [34], the 5′-end seems to be preferred for a bimolecular parallel 
structure [38]. Alternatively, two TMPyP4 molecules may stack onto both 
external G-tetrads, and one of the binding sites is stabilized additionally by 
means of an electrostatic interaction with bases of the larger loop [7]. This 
explanation agrees with our results and corresponds to the binding sites 
depicted in Scheme 2. One of the weak binding sites has been placed near a 
loop, and it has been shown that the protonation of bases affects this site. 
The location of the third binding site is quite ambiguous. Previous literature 
proposing the existence of two weak binding sites locates one of the weak 
binding sites near the external grooves. The location of the third site is near 
the bottom G-tetrad [34] or near the external groove [36]. However, in the 
case of ckit2, the role of the terminal guanine base, linked to the dangling-
blunt-end conformer equilibria, cannot be discarded.  
These proposed mechanisms should be further refined on the basis of 
additional structural pictures derived from NMR and X-ray studies. The 
extraction of a mechanistic conclusion is always associated with some 
uncertainties and is by no means definitive. Here a compelling mechanism is 
postulated that is open to rigorous theoretical and experimental tests. 
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 Data analysis 
Spectra recorded along acid-base titrations, melting experiments or mole ratio studies 
were analyzed by means of multivariate analysis methods. The procedures and the 
software used to analyze data have been extensively explained elsewhere (Bucek, 2009; 
del Toro, 2009; Jaumot et al, 2011), and only a short description will be given here. 
The goal of the data analysis was to calculate the distribution diagrams and pure 
(individual) spectra for all the spectroscopically-active species considered throughout 
the experiment. The distribution diagram provides information about the stoichiometry 
and stability of the species considered in case of acid-base and mole-ratio experiments. 
In addition, the shape and intensity of the pure spectra may provide qualitative 
information about the structure of the species. 
With this goal in mind, measured spectra were arranged in a data matrix D and later 
decomposed according to Beer-Lambert-Bouer’s law in matrix form: 
D = C ST + E          (1) 
where C is the matrix containing the distribution diagram, ST is the matrix containing 
the pure spectra, and E is the matrix of data not explained by the proposed 
decomposition. 
The mathematical decomposition of D according to equation 1 may be done basically in 
two different ways, depending on whether a physico-chemical model is initially 
proposed (hard-modelling approach) or not (soft-modelling approach). 
For mole-ratio experiments, the physico-chemical model is similar to the previous one. 
For example: 
DNA + qL ↔ DNA•Lq   Beta1q= [DNA•Lq] / [DNA] [L]q (3) 
Whenever a physico-chemical model is applied, the distribution diagram complies with 
the proposed model. Accordingly, the proposed values for the equilibrium constants and 
the shape of the pure spectra are refined to explain satisfactorily data in D, whereas 
residuals in E are minimized. 
The application of hard-modelling methods (i.e., those based on compliance with a 
previously proposed model) has advantages and drawbacks. Hence, not only the 
calculated distribution diagrams and pure spectra are more robust in relation to the 
experimental noise, but reliable values for the thermodynamic parameters (stability 
constants) may be calculated, too. In addition, mixtures of two or more species may be 
resolved with acceptable incertitude when the stability constants have been calculated 
unambiguously. The main drawback, however, is the compulsory proposal of a model. 
Very often, it is difficult to find the most appropriate model to explain a given process 
and the chemical intuition is needed to replace this incertitude. However, data in matrix 
D may include variance due to other factors unrelated to the process studied (base line 
drift, impurities…) and cannot be appropriately modelled. 
The mathematical decomposition of D into matrices C, ST, and E may also be done 
without applying a physico-chemical model, which is known as soft-modelling. In this 
case, the calculation of matrices C and ST is based on compliance with a series of 
constraints which reduce the initially large number of mathematical solutions to 
(almost) a single physico-chemically meaningful solution. C and ST are calculated 
through an alternate optimization process until a previously set degree of convergence is 
reached. The application of soft-modelling methods is proposed whenever a physico-
chemical model cannot be easily proposed. Its main drawback is, probably, the inability 
to resolve complex mixtures without the help of more complex experimental and data 
analysis setups (for instance, the simultaneous analysis of several data matrices 
corresponding to complementary experiments). Recently, several hybrid approaches 
which combine the advantages of hard- and soft-modelling methods have been 
proposed. 
 S1. CD-monitored melting experiments of TMPyP4:ckitG2 and TMPyP4:ckitG2T 
mixtures. (a) Spectra measured in function of temperature for a mixture of ckit2 (2.4 
µM) and TMPyP4 (7.4 µM); (b) Spectra measured in function of temperature for a 
mixture of ckit2T (2.5 µM) and TMPyP4 (7.4 µM). pH=7.1. Arrows indicate the 
spectral variation upon heating. 
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 S2. Mole-ratio experiment of TMPyP4 and ckitG2 monitored with molecular 
absorption spectroscopy. (a) Experimental molecular absorption spectra arranged 
recorded along the titration of a ckitG2 sample with TMPyP4. The concentration of 
DNA was 0.5 µM and the TMPyP4 concentration ranged from 0.1 to 1.9 µM. (b) 
(Experimental (blue symbols) versus calculated (green line) absorbances at 422 nm. 
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S3. Mole-ratio experiment of TMPyP4 and ckitG2 monitored with circular 
dichroism spectroscopy. Experimental circular dichroism spectra arranged recorded 
along the titration of a ckitG2 sample with TMPyP4. The concentration of DNA was 2.0 
µM, and the TMPyP4 concentration ranged from 0.0 to 6.3 µM. Arrows indicate the 
spectral variation upon addition of ligand. 
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 S4. Mole-ratio experiment of TMPyP4 and ckitG2T monitored with molecular 
absorption spectroscopy. (a) Experimental molecular absorption spectra arranged 
recorded along the titration of a ckitG2 sample with TMPyP4. The concentration of 
DNA was 2.9 µM and the TMPyP4 concentration ranged from 0.6 to 8.9 µM. (b) 
(Experimental (blue symbols) versus calculated (green line) absorbances at 422 nm. 
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S5. Mole-ratio experiment of TMPyP4 and ckitG2T monitored with circular 
dichroism spectroscopy. Experimental circular dichroism spectra arranged recorded 
along the titrations of a ckitG2T sample with TMPyP4. The concentration of DNA was 
2.5 µM, and the TMPyP4 concentration ranged from 0.0 to 7.4 µM. 
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 S6. Supplementary SPR results for the interaction of TMPyP4 with ckit2 and 
ckit2T when a 1:1 model was considered. (a) and (b) show the steady state affinity 
plot for the interaction of TMPyP4 with ckit2 and ckit2T, respectively. (c) and (d) show 
the SPR sensorgrams (black) with fitting (red) for the interaction of TMPyP4 with ckit2 
and ckit2T, respectively. The concentration of TMPyP4 increased from 1·10-8 M to 
3·10-7 (upper curve). 
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 S7. Spectroscopically-monitored acid-base titration of TMPyP4. (a) UV-visible 
molecular absorption spectra measured throughout the pH range 7.5 – 1.5 at 25oC and 
150mM ionic strength. (b) Calculated pure spectra with Equispec for each one of the 
two acid-base species considered. (c) Calculated distribution diagram. Blue line: 
deprotonated species. Green line: protonated species. 
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 S8. Spectroscopically monitored acid-base titration of a mixture of TMPyP4 and 
ckit2. Experimental molecular absorption spectra recorded throughout the titration of a 
mixture of TMPyP4 4.0 microM and ckit2 1.0 microM at 25oC. The inset shows the 
spectral shifts observed in the Soret region. 
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 S9. Spectroscopically monitored acid-base titration of a mixture of TMPyP4 and 
ckit2T. Experimental molecular absorption spectra recorded throughout the titration of 
a mixture of TMPyP4 3.8 microM and ckit2 1.5 microM at 25oC. The inset shows the 
spectral shifts observed in the Soret region. 
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 S10. Mole-ratio experiment involving ckit2 and TMPyP4 at pH 3.1 and 25oC. (a) 
Visible molecular absorption experimental spectra measured for the mixtures of 
TMPyP4 and ckitG2. CckitG2 = 0.4 – 6.6 µM. CTMPyP4 = 3.4 – 3.3 µM. (b) Calculated 
distribution diagram with Equispec. (c) Calculated pure spectra for each one of the four 
species considered. (d) Experimental (blue symbols) versus calculated (green line) 
absorbances at 422 nm. Blue line: ckitG2. Green line: TMPyP4. Red line: 1:1 complex. 
Cyan line: 1:2 complex. 
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 S11. Mole-ratio experiment involving ckit2T and TMPyP4 at pH 3.1 and 25oC. (a) 
UV-visible molecular absorption experimental spectra measured for the mixtures of 
TMPyP4 and ckitG2T. CckitG2T = 0.3 – 4.5 µM. CTMPyP4 = 3.3 – 3.1 µM. (b) Calculated 
distribution diagram with Equispec. (c) Calculated pure spectra for each one of the four 
species considered. (d) Experimental (blue symbols) versus calculated (green line) 
absorbances at 422 nm. Blue line: ckitG2T. Green line: TMPyP4. Red line: 1:1 
complex. Cyan line: 1:2 complex. 
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